Suven Life Sciences has informed that the details of securities dematerialized/ rematerialized during the quarter ended September 30, 2022, as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, have been furnished by KFin Technologies, Registrar & Transfer Agent (RTA) of the Company to the stock exchanges where the shares of the Company are listed. Letters confirming this from KFin Technologies dated October 11, 2022 are enclosed.
The above information is a part of company’s filings submitted to BSE.
